Quantitative in-situ determination of Zn and Fe in DRG
Systematic quantification of Zn in fresh or frozen autopsy specimens of normal DRG has not been reported. Total levels of Fe in DRG of FA patients and normal control subjects, however, are available [2]. Levels were 25.4±10.3 μg/g wet weight (mean ± S.D.) in 3 samples from FA patients and 28±13.4 μg/g wet weight (mean ± S.D.) in 8 normal controls. The difference was not significant. These results are now less applicable because the new method utilizing XRF can restrict measurements to neural tissues of DRG (Figure 1). While the relatively coarse steps (0.15 mm) of the scanning XRF instrument do not resolve the cellular localization of Zn or Fe, non-destructive XRF technology allows for intact tissue samples to be recovered, re-embedded in paraffin, sectioned, and stained for class-III-β-tubulin, Zip14, and ferritin. The critical step is matching XRF metal maps with stained tissue sections. Infiltration by PEG 1000 and PEG 1450 displaces all tissue water, and results expressed as μg metal/ml PEG 1450 (Figure 2) are equivalent to μg metal/ml tissue volume. The results of Zn and Fe can be converted to μg/g wet tissue weight by assuming DRG water content of at least 80 percent. When the mean XRF-recorded Fe levels in normal DRG (23.85 μg/ml PEG) and DRG of FA (19.99 μg/m PEG) are multiplied by 0.8, the result yields 19.08 μg/g wet weight for controls, and 16 μg/g wet weight for FA. These concentrations are lower than the chemical assay of whole DRG [2], reflecting the exclusion of capsule and pericapsular tissues by XRF technology.
Localization of Zn, Fe, and metal-related proteins in DRG
The normal human DRG may be similar to rat DRG, in which Pérez-Castejón et al. [7] visualized Zn in the cytoplasm of neurons by histochemistry and autoradiography. Velázquez et al. [8] also detected the metal by fluorescence microscopy and MT3 by immunofluorescence in rat DRG. Autolysis due to delayed autopsy imposes severe limitations on the visualization of Zn by chemical and metallographic methods. None of the DRG specimens obtained from the FA patients listed in Table 1 were fixed within the optimal time limit of under 2 h [9, 10]. Therefore, this research utilized the immunodetection of Zip14, MT1/2, and MT3 as surrogate markers of Zn, and ferritin as a marker of Fe. The intensity of Zip14 (Figures 3b and 4a) and MT3 immunofluorescence (Figure 5b) suggests that the bulk of Zn in normal DRG is located in the cytoplasm of neurons. In contrast to MT3, the more restrictive immunofluorescence of MT1/2 (Figure 5a and d) implies that this protein provides Zn homeostasis in normal (Figure 5a) and hyperplastic satellite cells (Figure 5d). While ferritin immunofluorescence is stronger in satellite cells than in neurons (Figure 4b), ferritin signal is also present in neurons where it co-localizes with Zip14 (Figure 4a).
Supportive evidence of Zn and Fe translocation in FA
The described observations establish that FA causes neither influx nor efflux of DRG Zn or Fe. Changes due to FA, however, are evident by immunofluorescence of several metal-handling proteins. The response of Zip14- and ferritin-immunoreactivity to FA is similar, suggesting the transition of Zn and Fe from degenerating neurons to satellite cells occurs by comparable mechanisms. It is likely that MT1/2 reacts to the transfer of Zn from neurons to satellite cells while MT3 remains restricted to smaller neurons (Figure 5e) and presumably disappears when atrophic nerve cells are totally absorbed into residual nodules.
Heretofore, MT3 was thought to be a unique central nervous system (CNS) protein [11], but its presence in DRG (Figure 5b) suggests that neuronal Zn homeostasis is similar.
In CNS, the most prominent Zn transporter is ZnT3, which packages Zn into synaptic vesicles (review in ref [9]). As expected, an antibody to ZnT3 did not generate an immunohistochemical reaction in DRG, which under normal circumstances are devoid of synapses. Zip transporters, including Zip14, are not specific for Zn, and it is noteworthy that the “i” in Zip derives from “iron” [12, 13]. Zip14 and MT3 may collaborate in Zn homeostasis of normal DRG neurons. While MT3 is a Zn storage and buffering protein, Zip14 adds Zn transport across plasma membranes. In some DRG neurons of FA, Zip14 immunofluorescence localizes to the cytoplasm just beneath the plasma membrane (Figure 4d). The transmembrane localization of functional Zn transporters may be relevant to this pathological phenomenon.
Origin and physiological role of Zn in normal human DRG are unknown. Velázquez et al. [8] reported that Zn in rat DRG may arise from retrograde axonal transport through dorsal spinal roots. It accumulated only in small-diameter DRG neurons, and the authors [8] considered a role in sensory processing. In humans with FA, loss of Zn-containing DRG neurons may contribute to the complex pathological phenotype observed in dorsal roots [2] and sensory peripheral nerves [14].
The role of satellite cells in FA
The greater abundance of satellite cells in FA accounts for the hypercellularity of DRG that is readily apparent on routine cell stains [2]. It is likely that the earliest response to the disease is the formation of multiple layers of satellite cells about neurons. This phenomenon is especially apparent by ferritin (Figure 4e) and MT1/2 immunofluorescence (Figure 5d). Residual nodules (Figure 4d-f) are a continuation of satellite cell hyperplasia beyond death of the neuron, but there is no insight yet about the fate of these cellular collections or whether they ultimately shed Zn and Fe into the blood stream.
In normal DRG, neuronal and satellite cell plasma membranes are very closely apposed, with multiple invaginations in both directions [15]. Also, satellite cells are tightly linked to each other. Beyond structural support, they handle “trafficking” into and out of DRG neurons. Pannese [15] also cited experimental studies, in which satellite cells provided “trophic support” to neurons. FA is typically a disease of nerve cells in the central nervous system (CNS) [1], and DRG neurons should therefore be similarly vulnerable to frataxin deficiency. It is a theoretical consideration that hyperplastic satellite cells, which also derive from the neural crest, do not adequately support their immediately adjacent neurons, and neuronal atrophy may be secondary.
The greater abundance of mitochondria in hyperplastic satellite cells and residual nodules in DRG of FA indicates that these cells develop a more active oxidative metabolism as part of the pathological phenotype (Figures 6e and 7f). In normal DRG, satellite cells contain few mitochondria (Figure 6b-c) whereas reaction product of ATP5B is very abundant in the closely apposed neuron. In promptly fixed normal DRG, the available monoclonal anti-frataxin antibody shows reaction product that strongly resembles the distribution of the mitochondrial marker ATP5B (Figure 7). It is apparent that lack of frataxin does not impair the proliferation of satellite cells and the processing of the protein to its mature functional form [16].
Endogenous metal toxicity or epiphenomenon?
A key question in the pathogenesis of the DRG lesion in FA is: Do Zn and Fe in the cytosol of neurons become toxic, or is the shift in metal-related proteins an epiphenomenon of frataxin deficiency? Human autopsy tissues do not lend themselves to the direct measurement of toxic radicals, but changes in the cellular localization of Zip14, MT1/2, MT3, and ferritin suggest a disturbance is Zn and Fe homeostasis. In the absence of a synaptic source of Zn, the mechanism of toxicity in DRG neurons may be similar to that in CNS neurons of ZnT3-deleted animals [17]. In the cytosol of CNS neurons, ionic Zn must be kept at picomolar or femtomolar levels to prevent toxicity and still meet metabolic demands [18]. It is likely that neurons in normal DRG maintain Zn homeostasis by buffering proteins such as MT3 (Figure 5b) and by sequestration of the metal in mitochondria [18]. The mean level of 8.16 μg/ml in normal DRG, reported in this study, is equal to a concentration of 124.8 μM. Neuronal toxicity is thought to occur at ionic Zn2+ levels in the range of 100 nM to 3 μM [18]. Therefore, the total pool of neuronal Zn in DRG is present in large excess over need, and control mechanisms must be very efficient. Dineley et al. [19, 20] summarized the evidence of endogenous Zn toxicity in the CNS, in which mitochondria bear the brunt of the damage. Mitochondrial impairment has many untoward effects: insufficient biosynthesis of adenosine triphosphate; decrease of mitochondrial membrane potential; release of cytochrome C and apoptosis-inducing factor; and generation of reactive oxygen species and nitric oxide [18]. All of these processes ultimately cause cell death. If they exist in FA in vivo, the untoward effects of Zn on DRG neurons are superimposed on deficient oxidative phosphorylation, which is a recognized effect of frataxin deficiency [4]. Fe in DRG may be less injurious than Zn because holoferritin has a prodigious ability to trap the metal. Therefore, the aggregation of Fe in the shell of ferritin in hyperplastic satellite cells may be protective against Fe-mediated oxidative injury.
Based on experiments with frataxin-deleted mice [21], human neonates with homozygous mutations of the FXN gene must have at least some normal frataxin to survive to the mean age of death (40±20 years [N=30; mean ± S.D.]; ref. [22]). It is likely that DRG are hypoplastic at birth in all patients with mutated FXN genes [1, 2, 23]. A superimposed atrophic process may lead to progressive destruction of neurons, principally by satellite cell invasion and absorption into residual nodules. This transition may be the reason why clinical “onset” of FA is delayed to a mean age of 15 years [24]. It may be proposed that in DRG, Zn and Fe dysmetabolism contribute to onset and progression. In contrast to brain, however, nothing is known about the rate by which DRG acquire Zn and Fe during growth. Extrapolating from human brain, it is unlikely that end-point Zn accumulation in DRG coincides with onset of FA [25].
Many questions remain: Does frataxin deficiency trigger endogenous metal toxicity; and why do DRG in FA retain Zn and Fe rather than shedding the metals into the blood stream? The hypothesized accelerated DRG destruction by endogenous metals does not contradict other potential mechanisms of increasing disease activity, such as somatic GAA expansion in postmitotic neurons through the activity of mismatch repair enzymes [26] or greater epigenetic gene silencing [27].